Page last updated: 2024-10-23

atenolol and Experimental Neoplasms

atenolol has been researched along with Experimental Neoplasms in 2 studies

Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.

Research Excerpts

ExcerptRelevanceReference
" The widespread and chronic use of these drugs has generated a concern for their potential chronic toxicity."2.37A toxicological review of beta-adrenergic blockers. ( Fishbein, L; Jackson, CD, 1986)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vesci, L1
Milazzo, FM1
Stasi, MA1
Pace, S1
Manera, F1
Tallarico, C1
Cini, E1
Petricci, E1
Manetti, F1
De Santis, R1
Giannini, G1
Jackson, CD1
Fishbein, L1

Reviews

1 review available for atenolol and Experimental Neoplasms

ArticleYear
A toxicological review of beta-adrenergic blockers.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1986, Volume: 6, Issue:3

    Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolami

1986

Other Studies

1 other study available for atenolol and Experimental Neoplasms

ArticleYear
Hedgehog pathway inhibitors of the acylthiourea and acylguanidine class show antitumor activity on colon cancer in vitro and in vivo.
    European journal of medicinal chemistry, 2018, Sep-05, Volume: 157

    Topics: Animals; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Colonic Neoplasms; Dos

2018